Preferred Drug List Review Panel

The Medicaid and NC Health Choice Preferred Drug List (PDL) Review Panel was established by NCDHHS to hold open meetings to discuss recommended policies and procedures related to the PDL as well as address public comments received during the PDL comment period. The administration and review of the NC Medicaid and NC Health Choice PDL follows the Preferred Drug List Review Panel Guidelines and Procedures.

PDL Review Panel Meetings

PDL Review Panel Meeting

1-5 p.m., Thursday, July 14, 2022 (Virtual Only)

Meeting Agenda

To register, click on the appropriate link below.

Attendee registration 

Speaker registration

Meeting Archives

2016-2021

Recommendations and Reports

PDL Panel Members

Aug. 1, 2020 – July 31, 2022
Panel Member Position Organization
Lawrence Greenblatt, MD Physician N.C. Physician Advisory Group Pharmacy and Therapeutics Committee
Christopher Heery, MD Physician Research-Based Pharmaceutical Company
Stephen Houser, MD Physician Old North State Medical Society
Casey Johnson, PharmD Pharmacist N.C. Association of Pharmacists
Karen Melendez, MD Physician Community Care of North Carolina
Anna Miller-Fitzwater, MD Physician N.C. Pediatric Society
Fern Paul-Aviles, PharmD Pharmacist Hospital-Based Pharmacy
Angela B. Smith, PharmD, DHA, FACHE Pharmacist Pharmacy Director, Division of Health Benefits
Jessica Triche, MD Physician N.C. Academy of Family Physicians
Duncan Vincent, MD, FACP Physician N.C. Chapter of the American College of Physicians
Theodore Zarzar, MD Physician N.C. Psychiatric Association

This page was last modified on 07/08/2022

https://medicaid.ncdhhs.gov/meetings-notices/committees-and-work-groups/preferred-drug-list-review-panel